USPTO 2015–2025 USPTO PatentsView US Corporation

Cellresin Technologies, Llc

USPTO PatentsView assignee record - 13 granted patents across 22 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: Y10T (TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION).

13
Total patents granted
22
CPC technology areas
14.5
Avg claims per patent
-100%
5-year filing velocity

The verdict

Cellresin holds 13 US patents across 22 technology areas, rank #20,937 of 50,000 tracked assignees.

#20,937
of 50,000 US assignees by volume
Top 52%
by Innovation Score (34.4/100)
14.5
avg claims per patent
-100%
filing velocity, last 5 yrs

Portfolio overview

Cellresin Technologies, Llc has been granted 13 US utility patents between 2015 and 2019, placing Cellresin Technologies, Llc at rank #20,937 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.5 claims per patent with primary concentration in Y10T (TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION). As a US Corporation, Cellresin Technologies, Llc is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 34.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 13 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cellresin Technologies, Llc's 14.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cellresin Technologies, Llc against peers pursuing similar technology classes.

How does Cellresin compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Cellresin holds 13 patents, placing it at rank #20,937 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Cellresin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

34 Top 52% higher than 48% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

012345 20152016201720182019 4
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cellresin Technologies, Llc patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 7.7%
2016 3 23.1%
2017 4 30.8%
2018 1 7.7%
2019 4 30.8%

Which technologies does Cellresin Technologies, Llc patent most?

Top 15 of 22 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#20,937

Across all tracked assignees

Innovation Score

34.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cellresin Technologies, Llc hold?
Cellresin Technologies, Llc holds 13 US granted patents filed between 2015 and 2019, spanning 22 technology areas.
What is Cellresin Technologies, Llc's Innovation Score?
Cellresin Technologies, Llc has an Innovation Score of 34.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Cellresin Technologies, Llc focus on?
Cellresin Technologies, Llc's top technology area is Y10T (TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION) with 11 patents. The company has filed patents in 22 CPC subclasses total.
Is Cellresin Technologies, Llc's patent filing rate increasing or decreasing?
Cellresin Technologies, Llc's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Cellresin Technologies, Llc's patents?
Cellresin Technologies, Llc's patents average 14.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Cellresin Technologies, Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Cellresin's 13 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Cellresin ranks #20,937 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in Y10T - see who else leads that technology area. Y10T leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.